GSK2012-D Dummy Electronic Health Record Text Data

Description: This corpus consists of two corpora: a text data extracted from the database of “inter-university clinical informatics education program for co-medical students”, and the sub-corpus with medical annotations.
See the attached manual for more information.
The expiration date of this language resource is until March 31, 2016. The user shall submit the annual utilization report in a way that GSK specifies.
Creator: The Joint Use Conference for Electronic Health Care Education (JUCEE)
Eiji ARAMAKI (Center for Knowledge Structuring, The University of Tokyo) (Design Unit, Kyoto University)

Free Limited Distribution Language Resources for GSK Members. GSK Members can use the “Free Limited Distribution Language Resource to GSK Members” Service completely free of charge, limited to one time throughout a given year. In the event that a member uses this service for any “Free Limited Distribution Language Resource for GSK Members” more than once during any given year, a charge of 5,500 yen per incident (excluding shipping fees and applicable taxes) will be assessed. A sum of 33,000 yen (including shipping fees and applicable taxes) will be charged per incident for non-members. In the case of overseas delivery, it shall be determined case by case.

Format:1 file (260KB, zip archive)
Sample: Sample-1 (txt)
Sample-2 (xml)

For acquiring the above language resource, fill out all necessary items on the Application for and Compliance of Use Form (for above resource only), and send to our office via email, fax, or postal service. We will send you the language resource via email. In the case of receipt as a paid resource, we will send documents including the billing statement through return mail. Please insure the proper billing address is indicated on the application, if different from your address. Also make sure to reference our page on “Membership and Usage Types for Individuals and Groups” concerning the Application for and Compliance of Use Form.

Please contact the GSK office for the case except the above.